The phosphatase domains of LAR, CD45, and PTP1B: structural correlations with peptide-based inhibitors1
- 1 February 2000
- journal article
- Published by Canadian Science Publishing in Biochemistry and Cell Biology
- Vol. 78 (1) , 39-50
- https://doi.org/10.1139/o99-069
Abstract
PTP1B is a cytosolic protein tyrosine phosphatase that is a regulator of the kinase activity of the insulin receptor; the two protein tyrosine phosphatases LAR and CD45 are receptor type phosphatases crucially important to cell function. LAR also is involved in regulation of the insulin receptor while CD45 is critical for T-cell activation. Although LAR and CD45 are both transmembrane phosphatases, these enzymes manifest their phosphatase activity through a catalytic cytosolic domain. We have utilized X-ray coordinates of related phosphatases (RPTPalpha and RPTPµ) and comparative protein modeling to obtain molecular models of the D1 catalytic domains of CD45 and LAR. The models were tested using established protocols and found to be comparable to low resolution X-ray structures. The structure obtained for LAR was compared with the recently reported X-ray structure. Both the CD45-D1 and LAR-D1 structures were then compared to and contrasted with PTP1B. The active site of pockets of the three enzymes were found to be very uniform in structure and charge distribution. Also, the gross surface topology around the active site was found to be somewhat similar for the 3 phosphatases. However, there were significant differences in surface topology, and, more importantly, large changes in surface charge distribution. The differences between the surface features of these enzymes provide an explanation for the selectivity of inhibition by a number of peptides.Keywords
This publication has 36 references indexed in Scilit:
- Nuclear Magnetic Resonance and Restrained Molecular Dynamics Studies of the Interaction of an Epidermal Growth Factor-Derived Peptide with Protein Tyrosine Phosphatase 1B,Biochemistry, 1999
- Modeling Studies of the Interactions between the Insulin Receptor Kinase Domain and Protein Tyrosine Phosphatase 1BJournal of the American Chemical Society, 1999
- Suppression of insulin receptor activation by overexpression of the protein-tyrosine phosphatase LAR in hepatoma cellsCellular Signalling, 1996
- The Transmembrane Protein-tyrosine Phosphatase LAR Modulates Signaling by Multiple Receptor Tyrosine KinasesJournal of Biological Chemistry, 1996
- CD45 protein tyrosine phosphatase: Determination of minimal peptide length for substrate recognition and synthesis of some tyrosine-based electrophiles as potential active-site directed irreversible inhibitorsBioorganic & Medicinal Chemistry Letters, 1995
- Protein classification by stochastic modeling and optimal filtering of amino-acid sequencesMathematical Biosciences, 1994
- Substrate specificities of catalytic fragments of protein tyrosine phosphatases (HPTPβ, LAR, and CD45) toward phosphotyrosylpeptide substrates and thiophosphotyrosylated peptides as inhibitorsProtein Science, 1993
- Structural analysis based on state‐space modelingProtein Science, 1993
- Basic local alignment search toolJournal of Molecular Biology, 1990
- Dictionary of protein secondary structure: Pattern recognition of hydrogen‐bonded and geometrical featuresBiopolymers, 1983